Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.28%
1,085.81
+3.01
+0.28%
—1,082.801,079.311,090.181,079.31——
SIXC
Communications
SIXC
Communications
SIXC
+0.65%
607.69
+3.92
+0.65%
—603.77603.77611.65602.09——
SIXE
Energy
SIXE
Energy
SIXE
-1.55%
1,192.38
-18.81
-1.55%
—1,211.191,203.051,203.481,182.72——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.02%
1,756.39
+0.40
+0.02%
—1,755.991,759.061,761.741,747.23——
SIXM
Financials
SIXM
Financials
SIXM
-0.82%
633.27
-5.24
-0.82%
—638.51637.93640.10631.89——
SIXR
Staples
SIXR
Staples
SIXR
+1.12%
852.42
+9.46
+1.12%
—842.96843.54858.44843.54——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.22%
218.79
-0.49
-0.22%
—219.28219.28220.58218.64——
SIXT
Technology
SIXT
Technology
SIXT
-0.45%
3,711.69
-16.66
-0.45%
—3,728.353,745.063,745.063,675.02——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.48%
911.05
-4.43
-0.48%
—915.48914.49915.84907.90——
SIXV
Health care
SIXV
Health care
SIXV
+0.22%
1,500.66
+3.30
+0.22%
—1,497.361,500.651,514.701,495.89——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+1.73%
2,454.96
+41.79
+1.73%
—2,413.172,431.692,463.522,431.69——
BRNS:NASDAQ
Barinthus Biotherapeutics PLC - ADR
$0.70
+2.68%
(+0.018) 1D
May 27, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BRNS...
Open
$0.71
High
$0.71
Low
$0.68
Mkt. cap
28.65M
Avg. vol.
22.38K
Volume
4.36K
52-wk high
$2.92
52-wk low
$0.51
EPS
-$1.29
Beta
-0.43
Shares outstanding
40.85M
No. of employees
14
News stories
From sources across the web
Profile
Barinthus Biotherapeutics plc is a biotechnology company developing immunotherapies for infectious diseases, cancer and autoimmune diseases such as hepatitis B, HPV and prostate cancer. Formerly known as Vaccitech plc, in November 2023 the company announced that it had renamed itself to Barinthus Biotherapeutics plc. As of 2024, the company employs more than 100 people. Wikipedia
About Barinthus Biotherapeutics PLC - ADR
CEO-
Employees14
Founded2016
Headquarters-
SectorBiotechnology
Websitebarinthusbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-1.00K
-308.00K
374.00K
-
Cost of revenue
-1.00K
-308.00K
374.00K
-
Research and development expenses
6.61M
5.46M
3.44M
3.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.38M
5.15M
1.50M
2.53M
Operating expense
21.98M
10.53M
4.51M
5.93M
Total operating expenses
21.98M
10.23M
4.88M
5.93M
Operating income
-21.98M
-10.23M
-4.88M
-5.93M
Other non operating income
320.00K
-275.00K
-104.00K
39.00K
EBT including unusual items
-21.15M
-14.64M
-11.16M
-5.55M
EBT excluding unusual items
-21.15M
-10.04M
-4.59M
-5.55M
Income tax expense
-25.00K
-71.00K
-57.00K
-16.00K
Effective tax rate
0.12%
0.48%
0.51%
0.29%
Other operating expenses
-13.00K
-72.00K
-434.00K
-46.00K
Net income
-21.12M
-14.57M
-11.09M
-5.53M
Net profit margin
-
-
-
-
Earnings per share
-0.52
-0.24
-0.27
-0.14
Interest and investment income
523.00K
472.00K
406.00K
350.00K
Interest expense
-12.00K
-13.00K
-13.00K
-13.00K
Net interest expenses
511.00K
459.00K
393.00K
337.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-20.78M
-10.12M
-4.57M
-5.21M
Gain or loss from assets sale
-281.00K
-68.00K
104.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer